77536

Inducible nitric oxide synthase inhibitory effect of naphthopyranones from Paepalanthus sp: in vitro and in silico study in the reduction of Helicobacter pylori pathogenicity

Favoritar este trabalho

Inducible nitric oxide synthase inhibitory effect of naphthopyranones from Paepalanthus sp: in vitro and in silico study in the reduction of Helicobacter pylori pathogenicity

Ricardo Pereira Rodrigues, Juliana Santa Ardisson, Rita de Cássia R. Gonçalves, Rodrigo Rezende Kitagawa
Graduate Program of Pharmaceutical Sciences, Federal University of Espirito Santo – UFES, Marechal Campos Av., 1468, 29043-900 Vitoria, ES, Brazil;
[email protected]

Helicobacter pylori (H. pylori) is a gram-negative bacterium, identified as an etiologic agent in a variety of gastroduodenal diseases such as duodenal ulcer, gastric cancer and mucosa-associated lymphoid tissue. Its defense mechanism comprises the production of large amounts of urease protein creating a neutral microenvironment surrounding the bacterium and thus increasing the periplasmic pH [1–3]. The expression of urease protein leads to inducible nitric oxide synthase (iNOS) induction, enhancing the nitric oxide release that leads to an increase of the inflammatory process and tissue injury. H. pylori directly stimulates murine macrophage NO production through the induction of iNOS expression and represents a new and important immunologic role for this enzyme in the pathogenesis of H. pylori [4]. Nitric oxide (NO) is a molecular messenger synthesized by nitric oxide synthase (NOS) enzymes and is related to several physiological processes [5]. There is considerable interest in alternative therapies for the eradication of H. pylori using compounds from a wide range of natural products [6]. In the present study, we investigated the activity of the naphthopyranones 9,10-dihydroxy-5,7-dimethoxy-3-methyl-1H-naphtho[2,3-c]pyran-1-one (1) and 5-methoxy-3,4-dehydroxanthomegnin (2) that inhibited NO production in LPS-stimulated Raw 264.7 macrophages, without exerting cytotoxic effects on the cells. (1) presented an NO inhibitory effect of 99.5 ± 5.3% and whereas compound (2) inhibited 76.9 ± 4.1% both in the highest concentration tested. In order to evaluate the potential of binding of the tested compounds in iNOS protein, in silico studies were conducted on the murine iNOS crystallographic protein complex from the Protein Data Bank [7]. The GOLD [8] software was used to molecular docking calculations. The grid region for docking was set over the center of the binding site. The data from the present study indicates that the naphthopyranones exhibited significant anti-H. pylori activity, most likely by inhibiting the NO synthesis by iNOS protein and the molecular modeling studies of the main interactions of known inhibitors allows to define the fundamental binding properties for the determination of promising prototypes in the design of anti-H.pylori drugs.

Acknowledgments: FAPES; The National Postdoctoral Program (PNPD/Capes).

1 - Ladeira, M. S. P.; Salvadori, D. M. F.; Rodrigues, M. A. M. J. Bras. Patol. e Med. Lab. 2003, 39 (4), 335–342.
2 - Kusters, J. G.; van Vliet, A. H. M.; Kuipers, E. J. Clin. Microbiol. Rev. 2006, 19 (3), 449–490.
3 - Malaty, H. M. Best Pract. Res. Clin. Gastroenterol. 2007, 21 (2), 205–214.
4 - Gobert, A. P.; Mersey, B. D.; Cheng, Y.; Blumberg, D. R.; Newton, J. C.; Wilson, K. T. J. Immunol. 2002, 168 (12), 6002–6006.
5 - Jackson, S. a; Sahni, S.; Lee, L.; Luo, Y.; Nieduzak, T. R.; Liang, G.; Chiang, Y.; Collar, N.; Fink, D.; He, W.; Laoui, A.; Merrill, J.; Boffey, R.; Crackett, P.; Rees, B.; Wong, M.; Guilloteau, J.-P.; Mathieu, M.; Rebello, S. S. Bioorg. Med. Chem. 2005, 13 (8), 2723–2739.
6 - Damasceno, J.; Rodrigues, R.; Gonçalves, R.; Kitagawa, R. Molecules 2017, 22 (5), 786.
7 - Bernstein, F. C.; Koetzle, T. F.; Williams, G. J.; Meyer, E. F.; Brice, M. D.; Rodgers, J. R.; Kennard, O.; Shimanouchi, T.; Tasumi, M. Eur. J. Biochem. 1977, 80 (2), 319–324.
8 - Verdonk, M. L.; Cole, J. C.; Hartshorn, M. J.; Murray, C. W.; Taylor, R. D. Proteins Struct. Funct. Genet. 2003, 52 (4), 609–623.